A 52-year-old man with obesity and type 2 diabetes is found to have elevated liver enzymes and ultrasound findings consistent with non-alcoholic fatty liver disease (NAFLD). He drinks minimal alcohol. Which is the most appropriate strategy to assess his risk of advanced fibrosis in a general practice setting?